ReviewVaccines2017

TLR4 Signaling Pathway Modulators as Potential Therapeutics in Inflammation and Sepsis.

Nikolay N Kuzmich et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.